Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease

✍ Scribed by Eva de Lago; Paolo Urbani; José Antonio Ramos; Vincenzo Di Marzo; Javier Fernández-Ruiz

• Book ID: 113500677
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 232 KB
• Volume: 1050
• Category: Article
• ISSN: 0006-8993
• DOI: 10.1016/j.brainres.2005.05.024